Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'nci'
nci published presentations and documents on DocSlides.
Figure S1 . Effect of avutometinib on cell viability of NCI-H358 cells.
by amelia
The NCI-H358 cells were treated with avutometinib ...
NCI in 2017 What’s new in 2017?
by sherrill-nordquist
NCI in 2017 What’s new in 2017? Presented by Th...
NCI Experimental Therapeutics Clinical Trials Network
by tawny-fly
(ETCTN). Central IRB Education Day. 28 April 2015...
NCI-Molecular Analysis for Therapy Choice
by conchita-marotz
(NCI-MATCH / EAY131). A phase II precision medic...
NCI-Molecular Analysis for Therapy Choice
by phoebe-click
(NCI-MATCH or EAY131). Interim Analysis Results....
hpcdmeweb.nci.nih.gov NCI Data Management
by barbara
Environment. (DME). Downloading a Collection to a...
Pilot Collaboration Between
by briana-ranney
ETCTN UM1 and NCI-CC P30 programs . Jeff Moscow. ...
Example of drug development
by briana-ranney
Objectives of preclinical tests. Preclinical test...
Mapping the NCI Thesaurus and the Collaborative Inter-Lingu
by liane-varnes
Amanda Hicks. University of Florida. aehicks@ufl....
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
by mitsue-stanley
S. Percy Ivy, MD. Associate Chief, Senior Investi...
ISAC/ODP Priorities for Improvement
by celsa-spraggs
Where are we now?. 7/18/2016. 1. 2015 IM4Q DATA. ...
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
by lois-ondreau
S. Percy Ivy, MD. Associate Chief, Senior Investi...
Using Research to Inform Policy and Practice
by giovanna-bartolotta
Using Research to Inform Policy and Practice Sama...
Center for Biomedical Informatics and Information Technology (CBIIT)
by escapistlego
Presented By: . Anthony Kerlavage and Jose Galvez ...
Role of the Drug Project Team in Formulating the Initial Development Plan of NCI-IND agents
by gelbero
Jeff Moscow, MD. IDB, CTEP. Overall Process of NCI...
NCI Training Funding OpportunitiesThe Government Can HelpSusan Perki
by evans
2 NCI Grant Funding for Trainees PredoctoralPostdo...
NCI ANALYSIS REPORT Larnique Sugick
by bency
The National Core Indicators™ (NCI™) program i...
NCI Workshop: Issues in Post-Treatment Surveillance
by koa
Lalitha K. Shankar, MD, PhD,. Cancer Imaging Progr...
Individuals With ID/DD Who Communicate Nonverbally
by kamari239
Sarah Taub NCI Webinar Series: . January 28. th. ,...
CRF Harmonization and Standardization
by massimo137
Preparation for a Round 5 . CRF Review . Dianne M...
How Do Services for People with Intellectual and Developmental Disabilities Compare by Race and Eth
by moshe
Sarah Taub NCI Webinar Series. October 29. th. , 2...
Resources Workshop Attendees
by victoria
DO cancer slim Raja Mazumder, Lynn Schriml, El...
National Cancer Institute Case Study
by ida
Using Druva inSync, NCI transformed its approach t...
Common Terminology Criteria for Adverse Events (CTCAE) v.4:
by ceila
Updating a Cancer Research Standard. . Ann . Sets...
Oncology Clinical Trials
by holly
Sylvia . O’Neill, . MD . Executive Di...
Thank you for joining! Slides and a recording of this webinar will be made available tomorrow
by tracy
: . Presentations | National Core Indicators. and...
FA LSELY REPORTI NG N NCI DENT THI RD DEGREE A sdem ea
by sherrill-nordquist
50 3 Com mi tted on or after Sept 17 2001 The ou...
FALSELY REPORTING N NCI DENT THI RD DEGREE
by tawny-fly
50 2 Com mi tted on or after Sept 26 1979 The ou...
RK nd SA FR NCI rc al art ers ui li H Ne w or ed pr a
by mitsue-stanley
pri ari pr es er nt l ors prehe si ort cr ph f t ...
Role of the Drug Project Team in Formulating the Initial De
by kittie-lecroy
Jeff Moscow, MD. IDB, CTEP. Overall Process of NC...
Foldingfunnels,bindingfunnels,andproteinfunction
by alida-meadow
CHUNG-JUNGTSAI,SANDEEPKUMAR,BUYONGMA,RUTHNUSSINOVL...
Response to Challenging Behaviour
by lindy-dunigan
When …………….. is fine. Calm, relaxed, sm...
Supported Decision-Making:
by tatyana-admore
International Context and Exploration of Outcomes...
Systems
by lindy-dunigan
Pathways. Organs. Targets. Systems, Pathways and ...
ROAD MAP: Getting a Cancer Study Done at Jefferson
by ellena-manuel
Sylvia O’Neill, MD. Associate Director of Regul...
Chapter 3 The Reporting Entity
by danika-pritchard
and the . Consolidation of . Less-than-Wholly-Own...
Chapter 9 Consolidation Ownership Issues
by ellena-manuel
General Overview. The following topics are discus...
CTEP Protocol and Information Office (PIO) Overview
by luanne-stotts
CTEP MISSION . . The mission of the Cancer Thera...
Ibrutinib for Hairy Cell Leukemia
by pasty-toler
. A Brief Update of an Ongoing Trial. Jeff Jones...
Pamela Harris, M.D. Percy Ivy, M.D
by min-jolicoeur
.. Jeffrey Moscow, M.D.. James A. Zwiebel, M.D.. ...
Load More...
